A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans

  1. Suzanne Paradis,
  2. Michael Ailion,
  3. Alex Toker,
  4. James H. Thomas, and
  5. Gary Ruvkun
  1. Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, Boston, Massachusetts 02114 USA; Molecular and Cellular Biology Program of the University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington 98195 USA; Signal Transduction Group, Boston Biomedical Research Institute, Boston, Massachusetts 02114 USA; Department of Genetics, University of Washington, Seattle, Washington 98195 USA

Abstract

An insulin receptor-like signaling pathway regulatesCaenorhabditis elegans metabolism, development, and longevity. Inactivation of the insulin receptor homolog DAF-2, the AGE-1 PI3K, or the AKT-1 and AKT-2 kinases causes a developmental arrest at the dauer stage. A null mutation in the daf-16 Fork head transcription factor alleviates the requirement for signaling through this pathway. We show here that a loss-of-function mutation in pdk-1, theC. elegans homolog of the mammalian Akt/PKB kinase PDK1, results in constitutive arrest at the dauer stage and increased life span; these phenotypes are suppressed by a loss of function mutation in daf-16. An activating mutation inpdk-1 or overexpression of wild-type pdk-1 relieves the requirement for AGE-1 PI3K signaling. Therefore, pdk-1 activity is both necessary and sufficient to propagate AGE-1 PI3K signals in the DAF-2 insulin receptor-like signaling pathway. The activating mutation in pdk-1 requires akt-1 and akt-2 gene activity in order to suppress the dauer arrest phenotype of age-1. This indicates that the major function of C. elegans PDK1 is to transduce signals from AGE-1 to AKT-1 and AKT-2. The activatingpdk-1 mutation is located in a conserved region of the kinase domain; the equivalent amino acid substitution in human PDK1 activates its kinase activity toward mammalian Akt/PKB.

Keywords

Footnotes

  • Corresponding author.

  • E-MAIL Ruvkun{at}frodo.mgh.harvard.edu; FAX (617) 726-6893.

    • Received February 26, 1999.
    • Accepted April 20, 1999.
| Table of Contents

Life Science Alliance